At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
Pre-Menopausal Heavy Uterine Bleeding and Uterine Fibroids Study
The purpose of this study is to determine the efficacy of an oral investigational medication to decrease frequency and amount of uterine bleeding as well as size or volume of uterine fibroids.
In order to participate you must meet the following criteria:
- Have a diagnosis of uterine fibroids.
- Have heavy uterine bleeding during menstrual cycles.
- Are a pre-menopausal women 20 years of age or older.
You will be excluded from the study if any of the following criteria apply to you:
- Have endometriosis.
- Have osteoporosis.
- Are currently using any corticosteroid.
This is a partial list of eligibility requirements.